002422
vs
ROG
002422
ROG
Over the past 12 months, Sichuan Kelun Pharmaceutical Co Ltd has underperformed ROG, delivering a return of +4% compared to the ROG's +27% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
002422
ROG
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Intrinsic Value
28.97
CNY
Overvaluation 19%
ROG
Intrinsic Value
416.39
CHF
Undervaluation 24%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
|
35.62
CNY
|
|||||
|
Roche Holding AG
SIX:ROG
|
318
CHF
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
002422, ROG
002422, ROG
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Sichuan Kelun Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Roche Holding AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
002422, ROG
002422, ROG
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
|
|||||||||
|
|
Roche Holding AG
SIX:ROG
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Sichuan Kelun Pharmaceutical Co Ltd
47.2%
ROG
73.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
Operating Margin
Sichuan Kelun Pharmaceutical Co Ltd
12.6%
ROG
35%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
Net Margin
Sichuan Kelun Pharmaceutical Co Ltd
9.2%
ROG
20.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
FCF Margin
Sichuan Kelun Pharmaceutical Co Ltd
5.5%
ROG
17.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROE
Sichuan Kelun Pharmaceutical Co Ltd
7.3%
ROG
39.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROA
Sichuan Kelun Pharmaceutical Co Ltd
4.4%
ROG
12.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROIC
Sichuan Kelun Pharmaceutical Co Ltd
6.4%
ROG
19.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
ROCE
Sichuan Kelun Pharmaceutical Co Ltd
8%
ROG
29.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Sichuan Kelun Pharmaceutical Co Ltd | ||||
|
|
Roche Holding AG | ||||
Solvency Comparison
Sichuan Kelun Pharmaceutical Co...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
002422, ROG
002422, ROG
Performance By Year
002422, ROG
002422, ROG
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 002422 to other stocks
LLY
Eli Lilly and Co
More expensive
vs Sichuan Kelun Pharmaceutical C...
JNJ
Johnson & Johnson
More expensive
vs Sichuan Kelun Pharmaceutical C...
AZN
AstraZeneca PLC
More expensive
vs Sichuan Kelun Pharmaceutical C...
MRK
Merck & Co Inc
Cheaper
vs Sichuan Kelun Pharmaceutical C...
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
